CNBC Business

Home Depot is making the largest acquisition in its history as its sales growth stagnates.

Moderna will chart its post-Covid future Wednesday during its fifth annual "Vaccines Day," an investor event in Boston.

Researchers found Novo Nordisk's Ozempic could be manufactured for an estimated 89 cents to $4.73 for a month's supply, figures that include a profit margin.

The results are a sign that Altimmune can address an area of concern around weight loss drugs, which is that they shrink critical muscle mass.

The reassessment comes amid slower-than-excepted adoption of EVs, as well as the Biden administration revising emissions rules.

FanDuel, DraftKings, BetMGM, Penn Entertainment, Fanatics Betting & Gaming, Hard Rock Digital and bet365 will form the Responsible Online Gaming Association.

The membership warehouse BJ's Wholesale said it plans to open a dozen clubs this year and 10 to 12 clubs each year going forward.

The optimism follows the Chevrolet Camaro and Dodge Challenger — the Mustang's closest American competitors — ended production in December.

The approval is a win for Merck, which is working to diversify its revenue stream as its blockbuster cancer drug Keytruda nears a loss of market exclusivity.

Canada Goose said Tuesday that it will cut about 17% of its corporate workforce as consumers continue to pull back on discretionary spending. 

The Viking study results add to the growing excitement around the biotech company and its potential in the budding weight loss market.

Krispy Kreme will more than double its distribution to reach McDonald's restaurants nationwide.

The China-built BYD Seagull, a compact all-electric hatchback, starts at just 69,800 yuan (or less than $10,000).

Hyundai's Genesis is previewing the future of the growingly prominent luxury brand with a new large all-electric concept vehicle called the Neolun.

Boeing's next CEO must handle the company's safety crisis and quality problems as well as growing competition from Airbus and Chinese manufacturers.

Pacaso lists shares of vacation homes, generally an eighth but sometimes larger shares, and then facilitates the purchase, including financing if necessary.

Boeing CEO Dave Calhoun will step down at the end of 2024 in part of a broad management shakeup for the embattled aerospace giant.

Amgen is testing a monthly injection that works differently and appears to help patients maintain their weight loss even after they stop taking it.

The move is hardly shocking, given the acrimonious nature of the battle. In recent weeks, Disney has stepped up its attacks on Trian and Peltz.

Some patients are willing to pay more for GLP-1 weight loss drugs like Wegovy than others — and it's strongly correlated to their annual income.